Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 118,258 shares at $110.00 ($5.7M) on 2022-03-23, disclosed to the SEC on 2022-03-25.
Seasonal sale ($5.7M) by EVP, CFO — this insider has traded HZNP in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 66,626 | $0 | 0.0% |
| 2 | $110.00 | 26,090 | $2.9M | 50.5% |
| 3 | $110.01 | 11,699 | $1.3M | 22.7% |
| 4 | $110.01 | 11,699 | $1.3M | 22.7% |
| 5 | $110.00 | 1,481 | $163K | 2.9% |
| 6 | $110.00 | 663 |
| $73K |
| 1.3% |
| Total | $48.03 avg | 118,258 | $5.7M | 100% |
| Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |
| HZNP | SELL | 2020-08-25 | $4.5M | — | Filing → |